Wellcome Open Research (Oct 2024)

A human model of Buruli ulcer: Provisional protocol for a Mycobacterium ulcerans controlled human infection study. [version 2; peer review: 1 approved, 2 approved with reservations]

  • Stephen Muhi,
  • Daniel P. O'Brien,
  • Julia L. Marshall,
  • Gayle Ross,
  • Paul D.R. Johnson,
  • Laura K. Mackay,
  • Anand Ramakrishnan,
  • James S. McCarthy,
  • Marcel Doerflinger,
  • Euzebiusz Jamrozik,
  • Timothy P. Stinear,
  • Joshua Osowicki

Journal volume & issue
Vol. 9

Abstract

Read online

Critical knowledge gaps have impeded progress towards reducing the global burden of disease due to Mycobacterium ulcerans, the cause of the neglected tropical disease Buruli ulcer (BU). Development of a controlled human infection model of BU has been proposed as an experimental platform to explore host-pathogen interactions and evaluate tools for prevention, diagnosis, and treatment. We have previously introduced the use case for a new human model and identified M. ulcerans JKD8049 as a suitable challenge strain. Here, we present a provisional protocol for an initial study, for transparent peer review during the earliest stages of protocol development. Following simultaneous scientific peer review and community/stakeholder consultation of this provisional protocol, we aim to present a refined protocol for institutional review board (IRB) evaluation.

Keywords